Mollazadeh Samaneh, Saeedi Nikoo, Al-Asady Abdulridha Mohammed, Ghorbani Elnaz, Khazaei Majid, Ryzhikov Mikhail, Avan Amir, Hassanian Seyed Mahdi
Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Student Research Committee, Islamic Azad University, Mashhad Branch, Mashhad, Iran.
Curr Pharm Des. 2025;31(6):432-442. doi: 10.2174/0113816128327773240827062719.
Hepatocellular carcinoma (HCC) is influenced by several factors, among which genetic polymorphisms play a key role. Polymorphisms in various genes affect key pathways involved in HCC development, including metabolism, expression of inflammatory cytokines, cell proliferation, and apoptosis regulation. These polymorphisms induce differential effects on susceptibility to HCC, disease progression, and treatment outcomes. Understanding the effect of genetic variations on HCC pathogenesis is essential to elucidate underlying mechanisms and identify potential therapeutic targets. This review explores the diverse roles of genetic polymorphisms in HCC, providing insights into the complex interplay between genetic factors and disease development.
肝细胞癌(HCC)受多种因素影响,其中基因多态性起着关键作用。各种基因中的多态性会影响HCC发展过程中涉及的关键途径,包括代谢、炎性细胞因子的表达、细胞增殖和凋亡调控。这些多态性对HCC易感性、疾病进展及治疗结果产生不同影响。了解基因变异对HCC发病机制的影响对于阐明潜在机制和确定潜在治疗靶点至关重要。本综述探讨了基因多态性在HCC中的多种作用,为深入了解遗传因素与疾病发展之间的复杂相互作用提供了见解。